Bank of New York Mellon’s Whitehawk Therapeutics WHWK Stock Holding History

Bank of New York Mellon’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$378K	Buy	+82,632	New	+$344K	﹤0.01%	3882
2024 Q2	–	Sell	-43,858	Closed	-$103K	–	4283
2024 Q1	$103K	Sell	43,858 -6,160	-12%	-$11.9K	﹤0.01%	4032
2023 Q4	$101K	Buy	50,018 +815	+2%	+$3.42K	﹤0.01%	4081
2023 Q3	$238K	Buy	49,203 +496	+1%	+$2.88K	﹤0.01%	3899
2023 Q2	$333K	Buy	48,707 +2,812	+6%	+$21.9K	﹤0.01%	3786
2023 Q1	$332K	Sell	45,895 -552	-1%	-$5.9K	﹤0.01%	3698
2022 Q4	$596K	Buy	46,447 +672	+1%	+$8.77K	﹤0.01%	3464
2022 Q3	$647K	Buy	45,775 +3,790	+9%	+$49.8K	﹤0.01%	3441
2022 Q2	$517K	Buy	41,985 +30,679	+271%	+$456K	﹤0.01%	3562
2022 Q1	$192K	Hold	11,306	–	–	﹤0.01%	4257
2021 Q4	$273K	Buy	+11,306	New	+$284K	﹤0.01%	4137
2019 Q1	–	Sell	-1,425	Closed	-$36K	–	4266
2018 Q4	$36K	Buy	+1,425	New	+$45.4K	﹤0.01%	4102

Other funds holding WHWK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Bank of New York Mellon's WHWK Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 82,632 shares worth $378K. The stake represents ﹤0.01% of the portfolio and ranks #3882 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in WHWK as recently as Q1 2024.

Bank of New York Mellon first reported a position in WHWK in Q4 2018 and has held it in 12 quarters since. The position peaked at $647K in Q3 2022. 27 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

Bank of New York Mellon held 82,632 shares of Whitehawk Therapeutics worth $378K as of Q2 2026.
Whitehawk Therapeutics was a new Bank of New York Mellon position in Q2 2026.
Whitehawk Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3882 holding.
Bank of New York Mellon first reported a position in Whitehawk Therapeutics in Q4 2018 and has held it in 12 quarters since.
Bank of New York Mellon's Whitehawk Therapeutics position peaked at $647K in Q3 2022.
27 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.